This Biotech Stock Winner Is Up 72%, but Trim Signals Reset
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
First-time investors can benefit greatly from expert advice. Learn key strategies to navigate the investment landscape effectively.
28,248 articlesA biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
As Treasury yields swing this spring, many in the top tax bracket are choosing tax-free municipal bonds. A fund model...
Silver prices have surged, lifting miners' profits and spurring a new wave of income-focused ETFs. Three TSX-listed f...
As bond markets flash warnings and oil risk climbs from Gulf tensions, a leading wall street strategist warns that th...
Pricing power has long been Apple’s ace. Now the company faces a no-win pricing trap: raise prices risking demand, or...
New hiring data arrives as investors weigh whether layoffs to boost efficiency undermine long-term growth. Experts wa...
BYD again proves it can set records, this time overseas. The question for investors is how long that momentum lasts a...
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
A shifting housing supply could change how loans are priced and approved. This article breaks down what oversupply me...
Peter Buffett’s late discovery of his father’s billionaire status tracks a broader story about wealth, privacy, and r...
As fintech payments consolidates, private equity eyes these three beaten-down names, weighing growth, cash flow, and ...
Elon Musk signals a shift in hiring, prioritizing conversation over credentials with a rule he describes as don’t loo...